Prolong Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Prolong Pharmaceuticals's estimated annual revenue is currently $5.4M per year.
- Prolong Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Prolong Pharmaceuticals has 27 Employees.
- Prolong Pharmaceuticals grew their employee count by -7% last year.
Prolong Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Innovation | Reveal Email/Phone |
2 | Materials Manager | Reveal Email/Phone |
3 | Microbiology Manager | Reveal Email/Phone |
4 | Maintenance Technician IV | Reveal Email/Phone |
Prolong Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Prolong Pharmaceuticals?
Headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC is developing products to treat several diseases and their debilitating comorbidities which cause reduced quality of life, increased medical costs and significant mortality. Comorbidities are a common consequence of sickle cell disease, chemotherapy, atherosclerosis, diabetes and many other diseases. - The company's lead product, SANGUINATEâ„¢, is focused on treating the comorbidities of sickle cell disease and hemorrhagic stroke - Prolong has a long-acting 3rd generation biologic in clinical development for the treatment of anemia, a comorbidity common with chronic kidney disease and cancer chemotherapy - Other products are also in development for comorbidities that result from diseases such as cardiovascular disorders and cancer ___________
keywords:N/AN/A
Total Funding
27
Number of Employees
$5.4M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.1M | 27 | N/A | N/A |
#2 | $4.6M | 27 | 0% | N/A |
#3 | $5.8M | 32 | -3% | N/A |
#4 | $3.7M | 32 | 7% | N/A |
#5 | $5.3M | 33 | 0% | $54M |